When Tech and Biotech merge, Google and Sanofi partner up to revolutionize Diabetes Management

31/08/2015 - 2 minutes

Taking care of diabetes is still far too complex currently. In future, Sanofi and Google will jointly take care of this problem, hoping to ease the life of millions of people with type 1 and type 2 diabetes.

When it comes to transforming our diabetes treatment technology, Google loves European Pharmas. Together with Novartis, it is developing the famous smart lens that measures the glucose level within tears. French drugmaker Sanofi has become a new partner to develop further tools for an improved diabetes management.

And they really make up a nice couple. Sanofi’s expertise in diabetes treatment meets Google’s competence in analytics, miniaturized electronics and low power chip design. All kinds of areas within diabetes care will be explored to understand and treat the disease better. These include the development of health indicators such as blood glucose and hemoglobin A1c levels, as well as the integration of patient-reported information, medication regimens and sensor devices.

What can we expect from the intended technology?

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!